Historical record - last NADAC effective date: 5/19/2021
Product Information
DEXMETHYLPHENIDATE ER 20 MG CP is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $1.7400 per EA under NDC 00115168501. Its NADAC has been published 202 times since Jul 12, 2017.
FDA first approved this application on Nov 21, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Amneal Pharmaceuticals of New York LLCNDC
00115168501
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
5/19/2021
Active Ingredients
DEXMETHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA079108FDA Approved
11/21/2013
TE Code
AB
On Market Since
12/21/2015
Pharmacological Classes
Price Statistics
The NADAC for DEXMETHYLPHENIDATE ER 20 MG CP has been published 202 times since Jul 12, 2017, and over the history we have for it it has declined 68.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.7400 per EA |
|---|---|
| All-time high | $5.9234 (Sep 13, 2017) |
| All-time low | $1.7400 (May 19, 2021) |
| Median price | $4.1673 |
| Average price | $4.1760 |
| Largest weekly change | -38.7% (Feb 17, 2021) |
| Weeks tracked | 202 |
| Tracking since | Jul 12, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-68.7%
Last surveyed May 19, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals of New York LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dexmethylphenidate hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DEXMETHYLPHENIDATE ER 20 MG CP?
The current National Average Drug Acquisition Cost (NADAC) for DEXMETHYLPHENIDATE ER 20 MG CP, manufactured by Amneal Pharmaceuticals of New York LLC, is $1.7400 per EA (NDC 00115168501), effective May 19, 2021.
How has the price of DEXMETHYLPHENIDATE ER 20 MG CP changed over time?
Over the history we have for it, the NADAC for DEXMETHYLPHENIDATE ER 20 MG CP has declined 68.7%. It has been tracked across 202 weekly CMS publications since Jul 12, 2017.
What are the highest and lowest recorded NADAC prices for DEXMETHYLPHENIDATE ER 20 MG CP?
Since Jul 12, 2017, the NADAC for DEXMETHYLPHENIDATE ER 20 MG CP has ranged from a low of $1.7400 (May 19, 2021) to a high of $5.9234 (Sep 13, 2017), with a median of $4.1673 per EA.
Are there cheaper alternatives to DEXMETHYLPHENIDATE ER 20 MG CP?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DEXMETHYLPHENIDATE ER 20 MG CP, is $1.6924 per EA — about 3% below DEXMETHYLPHENIDATE ER 20 MG CP.
Who manufactures DEXMETHYLPHENIDATE ER 20 MG CP?
DEXMETHYLPHENIDATE ER 20 MG CP (NDC 00115168501) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.